Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys
923 trades
$2B in total
Open-market sales
1,038 trades
$2.3B in total
Insiders filing
464 insiders
Last 7 days
Trade type
Director
Praxis Precision MedicinesPRAX
Open-market sale10b5-1 plan06/2406/2611,600 sh12 trades$311.32avg.$3,611,322.3−83.2%
Principal Accounting Officer
Praxis Precision MedicinesPRAX
Open-market sale25/11/2025/11/2113,600 sh2 trades$192.08avg.$2,612,264.75−56.6%
General Counsel and Secretary
Praxis Precision MedicinesPRAX
Open-market sale25/11/2025/11/2125,130 sh4 trades$193.08avg.$4,852,207.42−54.7%
10% Owner
Praxis Precision MedicinesPRAX
Open-market sale25/10/1625/10/17313,910 sh10 trades$105.76avg.$33,198,219.56+18.0%
10% Owner
Praxis Precision MedicinesPRAX
Open-market sale25/10/1625/10/17313,910 sh10 trades$105.76avg.$33,198,219.56+18.0%
10% Owner
Praxis Precision MedicinesPRAX
Open-market sale25/10/1625/10/17313,910 sh10 trades$105.76avg.$33,198,219.56+18.0%
Lauren MastrocolaPrincipal Accounting Officer
Praxis Precision MedicinesPRAX
Open-market sale24/11/1424/11/155,188.34 sh$81.78$424,302.45−48.0%
Alex NemiroffGeneral Counsel and Secretary
Praxis Precision MedicinesPRAX
Open-market sale24/11/1424/11/158,239.33 sh$80.20$660,794.27−44.4%
Praxis Precision MedicinesPRAX
Open-market buy23/10/0523/10/1014,500 sh$1.75$25,375No record
Praxis Precision MedicinesPRAX
Open-market buy23/06/2723/06/2710,000 sh$1.06$10,600+28.6%
Praxis Precision MedicinesPRAX
Open-market buyAmendment23/03/2423/04/068,000 sh$0.87$6,960+20.8%
Praxis Precision MedicinesPRAX
Open-market buy23/03/2423/03/2750,000 sh$0.84$42,000+200.0%
Praxis Precision MedicinesPRAX
Open-market buy23/03/2423/03/278,000 sh$0.87$6,960−14.7%
CEO
Praxis Precision MedicinesPRAX
Open-market buy23/03/2323/03/2770,001.75 sh2 trades$0.86avg.$60,201.51No record